Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model
在高风险 VQ 模型中,帕纳替尼可增强骨髓瘤细胞对 MEK 抑制的敏感性
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-022-14114-z
Evan Flietner #, Zhi Wen #, Adhithi Rajagopalan, Oisun Jung, Lyndsay Watkins, Joshua Wiesner, Xiaona You, Yun Zhou, Yuqian Sun, Brock Kingstad-Bakke, Natalie S Callander, Alan Rapraeger, M Suresh, Fotis Asimakopoulos, Jing Zhang